Compare TTK HEALTHCARE with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE IPCA LABS TTK HEALTHCARE/
IPCA LABS
 
P/E (TTM) x 10.8 24.2 44.5% View Chart
P/BV x 1.6 8.7 18.1% View Chart
Dividend Yield % 1.0 0.1 705.2%  

Financials

 TTK HEALTHCARE   IPCA LABS
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
IPCA LABS
Mar-19
TTK HEALTHCARE/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1,2151,042 116.6%   
Low Rs610590 103.4%   
Sales per share (Unadj.) Rs444.4298.6 148.8%  
Earnings per share (Unadj.) Rs17.235.0 49.3%  
Cash flow per share (Unadj.) Rs27.649.4 55.9%  
Dividends per share (Unadj.) Rs5.003.00 166.7%  
Dividend yield (eoy) %0.50.4 149.0%  
Book value per share (Unadj.) Rs177.9247.1 72.0%  
Shares outstanding (eoy) m14.13126.35 11.2%   
Bonus/Rights/Conversions -ESOS-  
Price / Sales ratio x2.12.7 75.2%   
Avg P/E ratio x52.923.3 226.9%  
P/CF ratio (eoy) x33.016.5 200.1%  
Price / Book Value ratio x5.13.3 155.3%  
Dividend payout %29.08.6 338.2%   
Avg Mkt Cap Rs m12,894103,108 12.5%   
No. of employees `0002.313.4 17.2%   
Total wages/salary Rs m1,3077,874 16.6%   
Avg. sales/employee Rs Th2,715.72,807.0 96.7%   
Avg. wages/employee Rs Th565.3585.8 96.5%   
Avg. net profit/employee Rs Th105.4329.0 32.0%   
INCOME DATA
Net Sales Rs m6,27937,732 16.6%  
Other income Rs m78577 13.4%   
Total revenues Rs m6,35638,309 16.6%   
Gross profit Rs m4966,901 7.2%  
Depreciation Rs m1471,824 8.0%   
Interest Rs m34189 17.9%   
Profit before tax Rs m3935,465 7.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1491,042 14.3%   
Profit after tax Rs m2444,422 5.5%  
Gross profit margin %7.918.3 43.2%  
Effective tax rate %37.919.1 198.8%   
Net profit margin %3.911.7 33.1%  
BALANCE SHEET DATA
Current assets Rs m2,71723,778 11.4%   
Current liabilities Rs m1,57110,975 14.3%   
Net working cap to sales %18.333.9 53.8%  
Current ratio x1.72.2 79.8%  
Inventory Days Days32104 31.0%  
Debtors Days Days4766 70.8%  
Net fixed assets Rs m99120,368 4.9%   
Share capital Rs m141253 55.9%   
"Free" reserves Rs m2,37330,971 7.7%   
Net worth Rs m2,51431,224 8.1%   
Long term debt Rs m31,409 0.2%   
Total assets Rs m4,15845,507 9.1%  
Interest coverage x12.630.0 42.1%   
Debt to equity ratio x00 3.0%  
Sales to assets ratio x1.50.8 182.1%   
Return on assets %6.710.1 65.9%  
Return on equity %9.714.2 68.4%  
Return on capital %16.917.3 97.8%  
Exports to sales %3.645.9 7.8%   
Imports to sales %0.516.6 3.0%   
Exports (fob) Rs m22517,308 1.3%   
Imports (cif) Rs m316,266 0.5%   
Fx inflow Rs m22517,308 1.3%   
Fx outflow Rs m716,266 1.1%   
Net fx Rs m15411,042 1.4%   
CASH FLOW
From Operations Rs m1734,923 3.5%  
From Investments Rs m97-1,563 -6.2%  
From Financial Activity Rs m-307-1,832 16.8%  
Net Cashflow Rs m-381,528 -2.5%  

Share Holding

Indian Promoters % 65.4 45.9 142.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 11.4 32.5%  
FIIs % 5.2 25.3 20.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.4 148.3%  
Shareholders   12,723 36,892 34.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   VENUS REMEDIES  SHASUN PHARMA  SANOFI INDIA  J.B.CHEMICALS  ORCHID PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Apr 16, 2021 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS